BACK Stock Overview Does not have significant operations. More details
Risk Analysis + 2 more risks
See All Risk Checks {"enabled":false,"variant":{"name":"disabled","enabled":false},"ready":false,"error":null}
Capture your thoughts, links and company narrative
IMAC Holdings, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for IMAC Holdings Historical stock prices Current Share Price US$0.61 52 Week High US$7.75 52 Week Low US$0.47 Beta 0.20 1 Month Change -49.59% 3 Month Change -42.99% 1 Year Change -67.72% 3 Year Change -98.04% 5 Year Change -97.64% Change since IPO -99.45%
Recent News & Updates
Ignite Proteomics LLC Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Preding Breast Cancer Therapy Response Feb 10
IMAC Holdings Receives Notice from Nasdaq over Equity Rule Jan 24
IMAC Holdings Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10 Q Nov 23 IMAC Holdings, Inc. announced delayed 10-Q filing Nov 16
IMAC Holdings, Inc. announced that it expects to receive $3.74 million in funding from a group of investors Nov 14
Imac Holdings Inc. Announces the Launch of an Entirely New Precision Oncology Assay for Breast Cancer Treatment Decision Making Utilizing the Reverse Phase Protein Array (Rppa) Technology Through Its Newly Established Subsidiary, Ignite Proteomics Llc Sep 19 See more updates
Ignite Proteomics LLC Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Preding Breast Cancer Therapy Response Feb 10
IMAC Holdings Receives Notice from Nasdaq over Equity Rule Jan 24
IMAC Holdings Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10 Q Nov 23 IMAC Holdings, Inc. announced delayed 10-Q filing Nov 16
IMAC Holdings, Inc. announced that it expects to receive $3.74 million in funding from a group of investors Nov 14
Imac Holdings Inc. Announces the Launch of an Entirely New Precision Oncology Assay for Breast Cancer Treatment Decision Making Utilizing the Reverse Phase Protein Array (Rppa) Technology Through Its Newly Established Subsidiary, Ignite Proteomics Llc Sep 19
IMAC Holdings, Inc. Announces Resignation of Cary Sucoff as Director Sep 12 IMAC Holdings, Inc. announced delayed 10-Q filing Aug 16
IMAC Holdings, Inc. announced that it has received $1 million in funding Jun 19
IMAC Holdings, Inc. has filed a Follow-on Equity Offering in the amount of $10 million. Jun 15
IMAC Holdings, Inc. Announces Chief Executive Officer Changes May 26 IMAC Holdings, Inc. Announces Board Resignations Theralink Technologies, Inc. (OTCPK:THER) cancelled the acquisition of IMAC Holdings, Inc. (NasdaqCM:BACK) in a reverse merger transaction. May 08
IMAC Holdings, Inc. announced delayed annual 10-K filing Apr 02
Insufficient new directors Feb 14 IMAC Holdings, Inc. Announces Executive Changes
IMAC Holdings Receives Letter from Nasdaq Regarding Non-Compliance with the Minimum Stockholders’ Equity Requirement of $2.5 Million for Continued Listing on the Nasdaq Capital Market Under Listing Rule 5550(b)(1) Nov 25 IMAC Holdings, Inc. announced delayed 10-Q filing Nov 15
Insufficient new directors Nov 14
IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements Sep 28
IMAC Holdings, Inc. Receive Non-Compliance Letter from Nasdaq Sep 10
IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split to Regain Compliance Sep 08
Price target decreased by 17% to US$1.25 Aug 15
IMAC Holdings Provides Nasdaq Compliance Update Regarding Minimum Stockholders' Equity Requirement and Minimum Bid Price Requirement Aug 06 IMAC Holdings, Inc. announced that it has received $4.3 million in funding from Theralink Technologies, Inc. and other investors Jul 27
IMAC Holdings, Inc., Annual General Meeting, Jul 05, 2023 Jun 29
IMAC Holdings Receives A Non-Compliance Letter from the Listing Qualifications Department of the Nasdaq Stock Market Jun 03 Theralink Technologies, Inc. (OTCPK:THER) entered into a definitive agreement and plan of merger to acquire IMAC Holdings, Inc. (NasdaqCM:BACK) in a reverse merger transaction.
IMAC Holdings, Inc. announced delayed 10-Q filing May 16
IMAC Holdings, Inc.'s (NASDAQ:BACK) Business And Shares Still Trailing The Industry Apr 18
Consensus forecasts updated Dec 08
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Nov 17
Price target decreased to US$5.00 Nov 16
IMAC Holdings, Inc. Launches E-Commerce Website for Vitamin and Supplement Line Nov 04
IMAC Holdings Receives Notice from The Nasdaq Stock Market Regarding Minimum Bid Price Requirement Sep 27
IMAC Holdings, Inc. Announces Completion of Third Cohort of Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson's Disease Sep 10
Consensus estimates of losses per share improve by 10% Sep 02
IMAC Holdings, Inc. Announces Addition of Medical Weight Loss Services to IMAC Regeneration Centers Sep 02
Second quarter 2022 earnings: EPS and revenues exceed analyst expectations Aug 17 IMAC Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $3.925 million. Aug 17
IMAC Holdings, Inc. Adds Stretch Services At the Backspace Aug 11
Price target decreased to US$5.50 Jul 01
IMAC Holdings, Inc. Announces the Launch of Spinal Health and Wellness Products and Supplements Jun 16
IMAC Holdings, Inc., Annual General Meeting, Jul 06, 2022 May 18
IMAC Holdings, Inc. announced delayed annual 10-K filing Apr 01
IMAC Holdings, Inc. Announces Completion of Second Cohort of Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’S Disease Feb 17
IMAC Holdings, Inc. Announces Executive Changes Feb 10
Imac Holdings, Inc. Announces Relocates of Growing Clinic in St. Louis Area Jan 12
Third quarter 2021 earnings released: US$0.068 loss per share (vs US$0.12 loss in 3Q 2020) Nov 13
Is IMAC Holdings (NASDAQ:IMAC) Using Debt In A Risky Way? Oct 12
Consensus EPS estimates fall to -US$0.38 Aug 20
Price target decreased to US$3.50 Aug 20
Second quarter 2021 earnings released: US$0.15 loss per share (vs US$0.20 loss in 2Q 2020) Aug 13
IMAC Holdings, Inc. Announces Initiation of Second Cohort of Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease Jul 15
IMAC Holdings Launches Acute Care Services for Musculoskeletal Injuries Jul 03
IMAC Holdings, Inc. (NasdaqCM:IMAC) agreed to acquire Active Medical Center Ltd. Jun 26
IMAC Holdings, Inc. (NasdaqCM:IMAC) acquired Fort Pierce Chiropractic. Jun 15
IMAC expands Florida presence with Fort Pierce Chiropractic acquisition for undisclosed amount Jun 14
Imac Holdings, Inc. Introduces the Back Space - First In-Store Chiropractic and Spinal Care Location Within Walmart Jun 08
Consensus EPS estimates increase to -US$0.34 Jun 04
Consensus revenue estimates fall to US$14.3m May 22
First quarter 2021 earnings released: US$0.15 loss per share (vs US$0.18 loss in 1Q 2020) May 15
Analysts increase EPS estimates to -US$0.36 Mar 11
We Think IMAC Holdings (NASDAQ:IMAC) Has A Fair Chunk Of Debt Mar 06
Full year 2020 earnings released: US$0.45 loss per share (vs US$0.84 loss in FY 2019) Mar 06
Revenue and earnings miss expectations Mar 06
IMAC Holdings, Inc. Announces Completion of First Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease Mar 03
IMAC Holdings, Inc. Partners with Fortune 500 Company to Launch In-Store Spinal Care Feb 27 Shareholder Returns BACK US Healthcare US Market 7D -2.4% -2.6% 0.2% 1Y -67.7% -4.6% 23.1%
See full shareholder returns
Return vs Market: BACK underperformed the US Market which returned 23.1% over the past year.
Price Volatility Is BACK's price volatile compared to industry and market? BACK volatility BACK Average Weekly Movement 25.3% Healthcare Industry Average Movement 6.5% Market Average Movement 5.9% 10% most volatile stocks in US Market 18.3% 10% least volatile stocks in US Market 3.0%
Stable Share Price: BACK's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BACK's weekly volatility (25%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company IMAC Holdings, Inc. does not have significant operations. Previously, it owned and managed innovative medical advancements and care regeneration centers, and backspace clinics. The company was founded in 2000 and is headquartered in Brentwood, Tennessee.
Show more IMAC Holdings, Inc. Fundamentals Summary How do IMAC Holdings's earnings and revenue compare to its market cap? BACK fundamental statistics Market cap US$1.09m Earnings (TTM ) -US$5.78m Revenue (TTM ) US$72.05k
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) BACK income statement (TTM ) Revenue US$72.05k Cost of Revenue US$1.54m Gross Profit -US$1.47m Other Expenses US$4.31m Earnings -US$5.78m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -2.85 Gross Margin -2,040.82% Net Profit Margin -8,024.04% Debt/Equity Ratio -31.7%
How did BACK perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/12 00:13 End of Day Share Price 2025/02/12 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources IMAC Holdings, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Benjamin Haynor Alliance Global Partners Edward Woo Ascendiant Capital Markets LLC Benjamin Piggott D. Boral Capital LLC.
